Aarti Pharmalabs Limited (BOM:543748)
711.10
-22.90 (-3.12%)
At close: Apr 21, 2025
Aarti Pharmalabs Statistics
Total Valuation
BOM:543748 has a market cap or net worth of INR 66.79 billion. The enterprise value is 69.66 billion.
Market Cap | 66.79B |
Enterprise Value | 69.66B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | Feb 14, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 47.71M |
Valuation Ratios
The trailing PE ratio is 26.79.
PE Ratio | 26.79 |
Forward PE | n/a |
PS Ratio | 3.25 |
PB Ratio | 3.60 |
P/TBV Ratio | 3.78 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 27.94 |
EV / Sales | 3.39 |
EV / EBITDA | 16.04 |
EV / EBIT | 19.73 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.21 |
Debt / EBITDA | 0.89 |
Debt / FCF | n/a |
Interest Coverage | 14.13 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 10.72% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 9.82M |
Profits Per Employee | 1.19M |
Employee Count | 2,095 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.75% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +36.75% |
50-Day Moving Average | 737.29 |
200-Day Moving Average | 657.19 |
Relative Strength Index (RSI) | 55.86 |
Average Volume (20 Days) | 42,493 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543748 had revenue of INR 20.57 billion and earned 2.49 billion in profits. Earnings per share was 27.50.
Revenue | 20.57B |
Gross Profit | 9.15B |
Operating Income | 3.53B |
Pretax Income | 3.42B |
Net Income | 2.49B |
EBITDA | 4.34B |
EBIT | 3.53B |
Earnings Per Share (EPS) | 27.50 |
Balance Sheet
The company has 995.13 million in cash and 3.86 billion in debt, giving a net cash position of -2.87 billion.
Cash & Cash Equivalents | 995.13M |
Total Debt | 3.86B |
Net Cash | -2.87B |
Net Cash Per Share | n/a |
Equity (Book Value) | 18.57B |
Book Value Per Share | 204.97 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 44.47%, with operating and profit margins of 17.16% and 12.12%.
Gross Margin | 44.47% |
Operating Margin | 17.16% |
Pretax Margin | 16.62% |
Profit Margin | 12.12% |
EBITDA Margin | 21.11% |
EBIT Margin | 17.16% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 0.49%.
Dividend Per Share | 3.50 |
Dividend Yield | 0.49% |
Dividend Growth (YoY) | 75.00% |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | 0.48% |
Earnings Yield | 3.73% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |